NRG Energy Inc vs Nuwellis Inc — how do they compare? NRG Energy Inc trades at $108.2 (market cap $22.35B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: NRG Energy Inc is far larger — about 10159.1× Nuwellis Inc's market cap, and NRG Energy Inc pays a 1.79% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold NRG Energy Inc for 62 Days and Nuwellis Inc for 26 Days on average.
| NRG | NUWE | |
|---|---|---|
Market Cap | $22.35B | $2.20M |
Volume | 5,011,942 | 121,544 |
Sector | Utilities | Health |
52-Week High | $184.03 | $146.65 |
52-Week Low | $95.23 | $0.68 |
Typical Hold Time | 62 Days | 26 Days |
Enterprise Value | $46.30B | -$1.52M |
Dividend Yield | 1.79% | — |
Signals from Pluang's Aura AI — not financial advice
NRG Energy trades at $108.61, up 4.84% with bullish technical signals and strong analyst support. The stock shows robust fundamentals with $30.71B revenue, 2.56% net margin, and attractive valuation at P/E 28.28 and P/S 0.66. Recent developments include a transformative 1.2 GW Texas data center power project and LS Power acquisition driving growth. Cash flow trends improved significantly from 2023's negative $1.5B to 2025's positive $3.83B, though 2026 projects a temporary dip.
Outlook remains positive with 70% analyst buy ratings and $202.90 consensus target representing 87% upside. Key opportunities include data center expansion and customer-backed power projects, while risks involve elevated debt levels (56.42% debt-to-asset ratio) and recent earnings misses. The stock presents growth potential but requires monitoring of execution on major capital projects.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →